Life Saving Solutions for Modern Emergency Treatment

Our PARTNERS

AMT Emergency Injector

Our innovative design solves complex medication delivery issues.

The Problem

Today’s vials and syringes do not enable
safe effective drug delivery under severe 
conditions. Current emergency injectors are dated 
with numerous parts under tension at rest which
can lead to mechanical failure.

The Solution

The AMT emergency injector with pre-filled medication has been engineered to address these flaws. It provides a rugged, durable platform to expedite treatment of wounded.

The AMT emergency injector has a simplified design. The spring is not under tension at rest, allowing for extended shelf-life without risk of mechanical failure.

FEATURES

MULTIPLE DELIVERY ROUTES

Trauma and environment dictate which delivery method must be used. No other injector on the market has this capability.

Each AMT emergency injector has additional attachments that allow medicine to be delivered immediately via:

* Intramuscular
* Intranasal
* Intravenous
* Intraosseous

Visual and Tactile Cues

Each injector has distinctive features molded into the cap to allow for visual and tactile cues to ensure correct medication is administered in low-visibility environments.

Rugged & Durable Material

Made in the USA, our military-grade emergency injectors are ergonomic, waterproof, crushproof, and are designed to withstand the most challenging environments.

 

 

Contact Us for more information on AMT

  • This field is for validation purposes and should be left unchanged.

Executive Team

Our founders, with first-hand field knowledge and experience, know that lives could have been saved with this technology – and will be.

Frank X. Osborne

Frank X. Osborne

Co-Founder and Chief Executive Officer

Mr. Osborne is an entrepreneur with over 20 years of pharmaceutical and medical device experience, and is the driving force behind AMT.
Read More

Richard Weddle

Richard Weddle

Chief Operating Officer

Mr. Weddle has over 30 years of government and private sector experience. He is responsible for technology development, intellectual property protection, drug, and device design and development, as well as production, and also works on oversight of regulatory approval and partnership processes.
Read More

Richard Weddle

Richard Weddle

Chief Operating Officer

Mr. Weddle has over 30 years of government and private sector experience. He is responsible for technology development, intellectual property protection, drug, and device design and development, as well as production, and also works on oversight of regulatory approval and partnership processes.
Read More

Barbara Horton

Barbara Horton

Chief Financial Officer

Ms. Horton has over 25 years of deep financial experience across multiple industries.
Read More

Dr. Robert Mabry

Dr. Robert Mabry

Chief Medical Advisor

Doctor Mabry most recently served as the U.S. D.O.D. Principal Deputy Assistant Secretary of Defense for Health Affairs, the principal staff assistant and advisor to the Assistant Secretary of Defense for Health Affairs (ASD HA) for clinical policies and programs.
Read More

Dr. Robert Mabry

Dr. Robert Mabry

Chief Medical Advisor

Doctor Mabry most recently served as the U.S. D.O.D. Principal Deputy Assistant Secretary of Defense for Health Affairs, the principal staff assistant, and advisor to the Assistant Secretary of Defense for Health Affairs (ASD HA) for clinical policies and programs.
Read More

Lt. Col. (RET) Andrew Contreras, DPT

Lt. Col. (RET) Andrew Contreras, DPT

Senior Vice President - Military

As an AMT Co-Founder and co-inventor of key AMT technology, Lt. Col. (RET) U.S. Army, Dr. Andrew Contreras has unique emergency medical experience, as was required when serving with the U.S. Army’s 82nd Airborne.
Read More

Lt. Col. (RET) Andrew Contreras, DPT

Lt. Col. (RET) Andrew Contreras, DPT

Senior Vice President - Military

As an AMT Co-Founder and co-inventor of key AMT technology, Lt. Col. (RET) U.S. Army, Dr. Andrew Contreras has unique emergency medical experience, as was required when serving with the U.S. Army’s 82nd Airborne.
Read More

Mark Pursel

Mark Pursel

Vice President - Manufacturing

Mr. Pursel is an injection molding and material thermodynamics expert, as well as a designer of automation systems, and is co-inventor of key AMT technologies.
Read More

Mark Pursel

Mark Pursel

Vice President - Manufacturing

Mr. Pursel is an injection molding and material thermodynamics expert, as well as a designer of automation systems, and is co-inventor of key AMT technologies.
Read More

Vince Sigmund

Vince Sigmund

Vice President - Regulatory

Mr. Sigmund has over 20 years of medical regulatory compliance experience working with the U.S. FDA and other world regulatory bodies.
Read More

Vince Sigmund

Vince Sigmund

Vice President - Regulatory

Mr. Sigmund has over 20 years medical regulatory compliance experience working with the U.S. FDA and other world regulatory bodies.
Read More

Advisory Board

Lori A. Hoffman

Lori A. Hoffman

Ms. Hoffman is an Advisor to AMT and is the Senior Director of Alliance Management for Frontida BioPharm, Inc., a contract development and manufacturing organization (CDMO).
Read More

Lori A. Hoffman

Lori A. Hoffman

Ms. Hoffman is an Advisor to AMT and is the Senior Director of Alliance Management for Frontida BioPharm, Inc., a contract development and manufacturing organization (CDMO).
Read More

Janet Dillione

Janet Dillione

Ms. Dillione is an Advisor to AMT and is Director and member of the Board of Directors at CorMedix Inc.. a biopharmaceutical company delivering treatments for infection and inflammatory diseases.
Read More

Timothy S. Callahan

Timothy S. Callahan

Mr. Callahan is an advisor to AMT and is an accomplished life-sciences operating executive and board member with over 25 years of experience in the biopharma industry, most recently with Actavis plc (now Allergan).
Read More

Timothy S. Callahan

Timothy S. Callahan

Mr. Callahan is an advisor to AMT and is an accomplished life-sciences operating executive and board member with over 25 years of experience in the biopharma industry, most recently with Actavis plc (now Allergan).
Read More

Thani Jambulingam, PhD

Thani Jambulingam, PhD

Dr. Jambulingam is an Advisor to AMT and a professor in the Department of Pharmaceutical and Healthcare Marketing at the Erivan K. Haub School of Business, Saint Joseph’s University.
Read More

Dr. Peter G. Goldschmidt, MD, DrPH, DMS

Dr. Peter G. Goldschmidt, MD, DrPH, DMS

Dr. Goldschmidt is an advisor to AMT with over 40 years of experience. Dr. Goldschmidt is president of the World Development Group, a healthcare company specializing in healthcare quality assurance, patient safety, informatics, modeling and forecasting with emphasis on medical-device development.
Read More

Dr. Peter G. Goldschmidt, MD, DrPH, DMS

Dr. Peter G. Goldschmidt, MD, DrPH, DMS

Dr. Goldschmidt is an advisor to AMT with over 40 years of experience. Dr. Goldschmidt is president of the World Development Group, a healthcare company specializing in healthcare quality assurance, patient safety, informatics, modeling and forecasting with emphasis on medical-device development.
Read More

Richard Jaffe

Richard Jaffe

Mr. Jaffe is a legal and strategic advisor to AMT. Mr. Jaffe has over 30 years experience and specializes in corporate law, private equity, mergers and acquisitions, corporate governance, and venture capital.
Read More

Contact Us

  • This field is for validation purposes and should be left unchanged.